Cutaneous follicle center lymphoma, intrathoracic lymph nodes
ICD-10 C82.62 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, intrathoracic lymph nodes.
Cutaneous follicle center lymphoma (CFCL) is a subtype of non-Hodgkin lymphoma that primarily affects the skin and is characterized by the proliferation of follicle center (germinal center) B-cells. When CFCL involves the intrathoracic lymph nodes, it indicates a more advanced stage of the disease, often associated with systemic symptoms. Patients may present with localized skin lesions, which can be nodular or plaque-like, and may also experience B-symptoms such as fever, night sweats, and weight loss. The diagnosis is typically confirmed through a combination of clinical evaluation, imaging studies, and histopathological examination of biopsy samples. Staging is crucial in determining the extent of the disease and guiding treatment options, which may include localized radiation therapy, chemotherapy, or immunotherapy. The prognosis varies based on the stage at diagnosis and the patient's overall health, with early-stage disease generally having a better outcome.
Comprehensive clinical notes, pathology reports, imaging studies, and treatment plans.
Diagnosis and management of cutaneous lymphomas, staging evaluations, and treatment response assessments.
Ensure accurate documentation of symptoms and staging to support coding.
Detailed descriptions of skin lesions, biopsy results, and any systemic symptoms.
Evaluation of skin lesions suspected to be lymphoma and coordination with oncology for treatment.
Documenting the relationship between skin findings and lymph node involvement is crucial.
Used when a biopsy is performed to confirm CFCL.
Pathology report detailing the findings and diagnosis.
Ensure the report is linked to the correct diagnosis for accurate coding.
Common symptoms include skin lesions that may appear as nodules or plaques, along with systemic symptoms such as fever, night sweats, and unexplained weight loss.
